1IX
(~{S})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol
Find entries where: 1IX
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | (~{S})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol |
Synonyms | Nedisertib |
Identifiers | (~{S})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol |
Formula | C24 H21 Cl F N5 O3 |
Molecular Weight | 481.907 |
Type | NON-POLYMER |
Isomeric SMILES | COc1ccc(nn1)[C@H](c2cc(c(cc2Cl)F)c3c4ccc(cc4ncn3)N5CCOCC5)O |
InChI | InChI=1S/C24H21ClFN5O3/c1-33-22-5-4-20(29-30-22)24(32)16-11-17(19(26)12-18(16)25)23-15-3-2-14(10-21(15)27-13-28-23)31-6-8-34-9-7-31/h2-5,10-13,24,32H,6-9H2,1H3/t24-/m0/s1 |
InChIKey | MOWXJLUYGFNTAL-DEOSSOPVSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 55 |
Chiral Atom Count | 1 |
Bond Count | 59 |
Aromatic Bond Count | 23 |
Drug Info: DrugBank
DrugBank ID | DB16252 |
---|---|
Name | Nedisertib |
Groups | investigational |
Description | Nedisertib is under investigation in clinical trial NCT03770689 (Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer). |
Synonyms | Nedisertib |
Categories |
|
CAS number | 1637542-33-6 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 86292849 |
ChEMBL | CHEMBL4297629 |